BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

O

OvartiX at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

OvartiX at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
O
OvartiX
Cambridge, United Kingdom
Biotech
UK women's health biotech developing non-hormonal drugs for ovarian problems such as infertility and early ovarian ageing.
Panel
Tue Nov 10
12:20–13:00
Women’s Health at an Inflection Point: Redefining Treatment, Regulatory Pathways and Access
How women's health care is changing, from non-hormonal and disease-modifying drugs to new approval and payment routes and new ways of naming diseases.
with Eli Lilly, McKinsey & Company, Apikal Therapeutics +1 more
Therapeutic InsightsRegulatory Strategy

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at OvartiX

Tell us what you sell and we’ll find the people at OvartiX most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction